Anti-CCNT2/ CYCT2 monoclonal antibody

Anti-CCNT2/ CYCT2 antibody for FACS & in-vivo assay

Target products collectionGo to CCNT2/CCNT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2040-Ab-1/ GM-Tg-hg-MP2040-Ab-2Anti-Human CCNT2 monoclonal antibodyHuman
GM-Tg-rg-MP2040-Ab-1/ GM-Tg-rg-MP2040-Ab-2Anti-Rat CCNT2 monoclonal antibodyRat
GM-Tg-mg-MP2040-Ab-1/ GM-Tg-mg-MP2040-Ab-2Anti-Mouse CCNT2 monoclonal antibodyMouse
GM-Tg-cynog-MP2040-Ab-1/ GM-Tg-cynog-MP2040-Ab-2Anti-Cynomolgus/ Rhesus macaque CCNT2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2040-Ab-1/ GM-Tg-felg-MP2040-Ab-2Anti-Feline CCNT2 monoclonal antibodyFeline
GM-Tg-cang-MP2040-Ab-1/ GM-Tg-cang-MP2040-Ab-2Anti-Canine CCNT2 monoclonal antibodyCanine
GM-Tg-bovg-MP2040-Ab-1/ GM-Tg-bovg-MP2040-Ab-2Anti-Bovine CCNT2 monoclonal antibodyBovine
GM-Tg-equg-MP2040-Ab-1/ GM-Tg-equg-MP2040-Ab-2Anti-Equine CCNT2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2040-Ab-1/ GM-Tg-hg-MP2040-Ab-2; GM-Tg-rg-MP2040-Ab-1/ GM-Tg-rg-MP2040-Ab-2;
GM-Tg-mg-MP2040-Ab-1/ GM-Tg-mg-MP2040-Ab-2; GM-Tg-cynog-MP2040-Ab-1/ GM-Tg-cynog-MP2040-Ab-2;
GM-Tg-felg-MP2040-Ab-1/ GM-Tg-felg-MP2040-Ab-2; GM-Tg-cang-MP2040-Ab-1/ GM-Tg-cang-MP2040-Ab-2;
GM-Tg-bovg-MP2040-Ab-1/ GM-Tg-bovg-MP2040-Ab-2; GM-Tg-equg-MP2040-Ab-1/ GM-Tg-equg-MP2040-Ab-2
Products NameAnti-CCNT2 monoclonal antibody
Formatmab
Target NameCCNT2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCNT2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CCNT2/ CYCT2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2040
    Target NameCCNT2
    Gene ID905,72949,304758,708813,476126,101088946,521089,100050510
    Gene Symbol and Synonyms2900041I18Rik,CCNT2,CYCT2,CycT2a,CycT2b
    Uniprot AccessionO60583
    Uniprot Entry NameCCNT2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000082258
    Target ClassificationN/A

    The target: CCNT2, gene name: CCNT2, also named as CYCT2. The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin and its kinase partner CDK9 were found to be subunits of the transcription elongation factor p-TEFb. The p-TEFb complex containing this cyclin was reported to interact with, and act as a negative regulator of human immunodeficiency virus type 1 (HIV-1) Tat protein. A pseudogene of this gene is found on chromosome 1. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.